Skip to main content

Webinar: (2022-04) Un-Common Rules: Navigating FDA-Regulated Research and the IRB

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Belinda Smith, MS, RD, CCRC

    Belinda Smith, Research Education Specialist for the University of Kentucky (UK) Office of Research Integrity (ORI), is a research education specialist with 34 years’ experience in human research, beginning with clinical research coordination and evolving into human subject protections. She currently oversees education and outreach for the University of Kentucky human research protection program. The UK Education Team utilize instructional design to create innovative education projects and initiatives. In addition, she provides FDA consultation for the Office of Research Integrity and Institutional Review Boards. She has co-authored publications and presented at national conferences in the areas of metabolic research, clinical research, and human research protection.

  • Kindra Cooper, JD, MPA, MA, CIP

    Kindra Cooper is the IRB Director at Creighton University in Omaha, Nebraska, and an Unaffiliated Board Member with Advarra. She is responsible for oversight of Creighton University’s Human Research Protection Program and two institutional review boards (Biomedical and Social/Behavioral). Kindra is a regulatory and life sciences attorney. She earned her JD at the University of Washington School of Law. She also holds a Master of Bioethics and Health Policy from Loyola University Chicago, and a Master of Public Administration from The George Washington University. Prior to her role at Creighton, Kindra served as an IRB Chairperson for Advarra and in-house Regulatory Counsel for Quorum IRB. She is a published author on topics including eConsent and mobile medical applications. She has presented at national conferences and via online webinars on topics including IRB Myths, eConsent, and IRB review of medical device research.

May 3, 2022
Tue 1:00 PM EDT

Duration 1H 15M

This live web event has ended.

Support Contact